SAB Biotherapeutics (SABSW) Short Interest Ratio & Short Volume

Short interest is the volume of SAB Biotherapeutics shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 300 shares of SABSW short. Learn More on SAB Biotherapeutics' current short interest.

SAB Biotherapeutics saw a decline in short interest in the month of July. As of July 31st, there was short interest totaling 300 shares, a decline of 92.5% from the previous total of 4,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to SAB Biotherapeutics: Cocrystal Pharma, Inc. (0.01%), CytoMed Therapeutics Limited (0.82%), Eloxx Pharmaceuticals, Inc. (0.08%), Galapagos NV (3.76%), Indivior PLC (6.48%), InterCure Ltd. (0.09%), Minerva Neurosciences, Inc (0.56%), NexImmune, Inc. (0.31%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

Short selling SABSW is an investing strategy that aims to generate trading profit from SAB Biotherapeutics as its price is falling. SABSW shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for SAB Biotherapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SABSW, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SABSW, twice per month. The most recent reporting period available is July, 31 2025.